iShares Genomics Immunology and Healthcare ETF — new fund registration

iSHARES TRUST registered 1 new fund series on Form 485APOS, filed 2019-03-14. Featured series: iShares Genomics Immunology and Healthcare ETF.

Registration

Registrant / trust: iSHARES TRUST
CIK: 0001100663
Form: 485APOS
Filed: 2019-03-14
State of incorporation: DE
Tickers: VLUE
Accession: 0001193125-19-074621
Reported net assets: $160.5M

Series & classes (1)

Series	Class	Ticker	New
iShares Genomics Immunology and Healthcare ETF	iShares Genomics and Immuno Biopharma ETF	IDNA	Yes

Fees (from the effective prospectus)

12b-1 fee: 0.00%
Gross expense ratio: 0.47%
Management fee: 0.47%
Other expenses: 0.00%

Investment objective

The iShares Genomics Immunology and Healthcare ETF (the Fund ) seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering.

Advisers

BlackRock Fund Advisors (Advisor)